Thursday, 30 May 2013

Yahoo! Finance: Biotechnology Industry News: Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings

Yahoo! Finance: Biotechnology Industry News
The latest news on the Biotechnology industry from Yahoo! Finance
Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
May 31st 2013, 00:30

[PR Newswire] - WASHINGTON, May 30, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced that data from the Phase III studies of tasimelteon in Non-24-Hour Disorder (Non-24) will be presented ...

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment